Consent and privacy in pharmacogenetic testing.
The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests for disease mutations, they might still reveal personal information that could be used adversely to a patient's interests. Informed consent and privacy of pharmacogenetic test results may be essential in most clinical uses of pharmacogenetic drugs.
Robertson
J A
JA
School of Law, The University of Texas, Austin, Texas 78705, USA. jrobertson@mail.law.utexas.edu
D003219:Confidentiality / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D010597:Pharmacogenetics / Q000331:legislation & jurisprudence*; D013678:Technology, Pharmaceutical / Q000379:methods*